EUVIMEDEUVIMED entdecken
Leitlinie

Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems

Jimmy Zheng, Alexander T Sandhu, Ankeet S Bhatt, Sean P Collins, Kelsey M Flint, Gregg C Fonarow, Marat Fudim, Stephen J Greene, Paul A Heidenreich, Anuradha Lala, Jeffrey M Testani, Anubodh S Varshney und 2 weitere

JACC: Heart Failure · 2025-01 · 13 (1) · 43-54

DOI: 10.1016/j.jchf.2024.08.004 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JACC: Heart Failure, 2025-01. Verfasst von Jimmy Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Heart Failure, Hospitalization, Angiotensin Receptor Antagonists, Stroke Volume. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains underused. Acute heart failure (HF) hospitalization represents a critical opportunity for rapid initiation of evidence-based medications. However, data on GDMT use at discharge are mostly derived from national quality improvement registries. OBJECTIVES: This study aimed to describe contemporary GDMT use patterns across HF hospitalizations at community-based health systems. METHODS: The authors identified HF hospitalizations from 2016 to 2022 in a U.S. database aggregating deidentified electronic health record data from more than 30 health systems. In-hospital and discharge rates of GDMT use were reported for eligible HFrEF patients. Factors associated with inpatient GDMT use and predischarge discontinuation were evaluated with the use of multivariable models. RESULTS: A total of 20,387 HF hospitalizations among 13,729 HFrEF patients were identified. Renin-angiotensin system inhibitors, beta-blockers, and mineralocorticoid receptor antagonists were administered during 70%, 86%, and 37% of eligible hospitalizations, respectively. Angiotensin receptor-neprilysin inhibitors and sodium-glucose cotransporter 2 inhibitors were used in 17% and 8% of eligible hospitalizations, respectively. Discharge GDMT rates were low. Triple/quadruple therapy was administered in 26% of hospitalizations, falling to 14% on discharge. Predischarge GDMT discontinuations were associated with inpatient hypotension, hyperkalemia, and worsening renal function, but 43%-57% had no medical contraindications. In adjusted analyses, use of 3 or more GDMT classes was associated with fewer 90-day all-cause deaths and HF readmissions compared with less comprehensive GDMT. CONCLUSIONS: Inpatient GDMT use in a national analysis of HF hospitalizations was lower than reported in quality improvement registries. High discontinuation rates emphasize an unmet need for inpatient and postdischarge strategies to optimize GDMT use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHospitalizationAngiotensin Receptor AntagonistsStroke VolumeMineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsHumansFemaleMaleAgedMiddle AgedUnited StatesPractice Guidelines as TopicGuideline AdherenceAngiotensin-Converting Enzyme InhibitorsInpatientsAged, 80 and overSodium-Glucose Transporter 2 InhibitorsCommunity Health Services

Stichwörter der Autor:innen

GDMThealth servicesheart failurehospitalizationquality of care

Substanzen

Angiotensin Receptor AntagonistsMineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Stanford University, Stanford, California, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California, USA; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
  • Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California, USA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Geriatric Research, Education, and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
  • Rocky Mountain Regional VA Medical Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Division of Cardiology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Zitieren

APA

Zheng, J., Sandhu, A. T., Bhatt, A. S., Collins, S. P., Flint, K. M., Fonarow, G. C., Fudim, M., Greene, S. J., Heidenreich, P. A., Lala, A., Testani, J. M., Varshney, A. S., Wi, R. S. K., & Ambrosy, A. P. (2025). Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems. JACC: Heart Failure, 13(1), 43-54. https://doi.org/10.1016/j.jchf.2024.08.004

Vancouver

Zheng J, Sandhu AT, Bhatt AS, Collins SP, Flint KM, Fonarow GC, et al. Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems. JACC: Heart Failure. 2025;13(1):43-54. doi:10.1016/j.jchf.2024.08.004

BibTeX
@article{Zheng2025,
  author = {Zheng, Jimmy and Sandhu, Alexander T and Bhatt, Ankeet S and Collins, Sean P and Flint, Kelsey M and Fonarow, Gregg C and Fudim, Marat and Greene, Stephen J and Heidenreich, Paul A and Lala, Anuradha and Testani, Jeffrey M and Varshney, Anubodh S and Wi, Ryan S K and Ambrosy, Andrew P},
  title = {Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems},
  journal = {JACC: Heart Failure},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {43--54},
  doi = {10.1016/j.jchf.2024.08.004}
}
Kostenlos starten →